课题基金 / 基金详情

SR Gene Therapy

SR Gene Therapy
SR基因治疗
批准号：
8934271
负责人：
TONY R. HUNTER
金额：
$10.84万
依托单位：
SALK INSTITUTE FOR BIOLOGICAL STUDIES
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-12-01 至 2018-11-30
来源：
https://reporter.nih.gov/project-details/8934271
关键词：
AgeBasic ScienceCancer BiologyCancer CenterCancer Center Support GrantConsultationsCustomDevelopmentGene TransferInstructionMetabolismMolecular BiologyNeurosciencesOncogenesProductionResearchResearch PersonnelResource SharingResourcesServicesSystemTechnologyViral VectorVirusanticancer researchdesignfield studygene therapynovel virusstem cell biologytherapeutic targettool

项目摘要

项目成果

TONY R. HUNTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The staff within the Gene Transfer, Targeting and Therapeutics Core (GTS) provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The GTS facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, ageing, cancer biology and gene therapy. All CCSG supported core are organized into one group: Basic Research. This shared resource is categorized as (1.03) Molecular Biology in summary ID
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative and Biostatistics Core
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
Histidine phosphorylation as a new target for cancer therapy
海外基金